Biomerica Inc - Asset Resilience Ratio
Biomerica Inc (BMRA) has an Asset Resilience Ratio of 1.44% as of August 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check BMRA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2018)
This chart shows how Biomerica Inc's Asset Resilience Ratio has changed over time. See Biomerica Inc balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Biomerica Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Biomerica Inc market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $165.32K | 1.44% |
| Total Liquid Assets | $165.32K | 1.44% |
Asset Resilience Insights
- Limited Liquidity: Biomerica Inc maintains only 1.44% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Biomerica Inc Industry Peers by Asset Resilience Ratio
Compare Biomerica Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
Annual Asset Resilience Ratio for Biomerica Inc (1999–2018)
The table below shows the annual Asset Resilience Ratio data for Biomerica Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-05-31 | 0.00% | $0.00 | $5.22 Million | -- |
| 2017-05-31 | 0.00% | $0.00 | $5.02 Million | -- |
| 2016-05-31 | 0.00% | $0.00 | $5.73 Million | -- |
| 2015-05-31 | 0.00% | $0.00 | $6.12 Million | -- |
| 2014-05-31 | 0.00% | $0.00 | $6.47 Million | -- |
| 2013-05-31 | 0.00% | $0.00 | $6.39 Million | -- |
| 2012-05-31 | 0.00% | $0.00 | $5.57 Million | -- |
| 2009-05-31 | 1.94% | $100.00K | $5.15 Million | +1.93pp |
| 2008-05-31 | 0.01% | $355.00 | $5.11 Million | -0.01pp |
| 2007-05-31 | 0.02% | $532.00 | $3.22 Million | -0.12pp |
| 2006-05-31 | 0.14% | $3.28K | $2.43 Million | -0.01pp |
| 2005-05-31 | 0.14% | $8.18K | $5.79 Million | -0.33pp |
| 2004-05-31 | 0.47% | $26.12K | $5.57 Million | +0.23pp |
| 2003-05-31 | 0.24% | $13.11K | $5.55 Million | +0.19pp |
| 2002-05-31 | 0.05% | $2.53K | $5.28 Million | -0.73pp |
| 2001-05-31 | 0.78% | $41.57K | $5.35 Million | -0.69pp |
| 2000-05-31 | 1.47% | $98.77K | $6.74 Million | +0.18pp |
| 1999-05-31 | 1.28% | $100.00K | $7.80 Million | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and oth… Read more